Allgens Medical Financials
| 688613 Stock | 17.15 0.22 1.27% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 35.9 M | 37.8 M |
|
|
Allgens | Select Account or Indicator |
Understanding current and past Allgens Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Allgens Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Allgens Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Allgens Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Allgens Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Allgens Medical's management manipulating its earnings.
Allgens Medical Stock Summary
Allgens Medical competes with Rising Nonferrous, Bloomage Biotechnology, Shandong Hongchuang, Sichuan Fulin, and Hefei Metalforming. Allgens Medical is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| Business Address | No 5 Kaikai |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.allgensmed.cn |
| Phone | 86 10 5633 0938 |
You should never invest in Allgens Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Allgens Stock, because this is throwing your money away. Analyzing the key information contained in Allgens Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Allgens Medical Key Financial Ratios
Allgens Medical's financial ratios allow both analysts and investors to convert raw data from Allgens Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Allgens Medical over time and compare it to other companies across industries.| Revenue | 226.48 M | ||||
| Gross Profit | 145.04 M | ||||
| EBITDA | (12.88 M) | ||||
| Net Income | 54.23 M | ||||
| Total Asset | 1.53 B |
Allgens Medical Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 804.9M | 1.4B | 1.5B | 1.5B | 1.8B | 1.1B | |
| Other Current Liab | 67.7M | 32.8M | 25.4M | 307.0K | 276.3K | 262.5K | |
| Net Debt | (28.9M) | 31.0M | (330.7M) | (198.3M) | (178.5M) | (169.5M) | |
| Retained Earnings | 83.1M | 190.8M | 239.2M | 276.0M | 317.4M | 333.3M | |
| Accounts Payable | 1.1M | 3.3M | 7.4M | 10.4M | 11.9M | 12.5M | |
| Cash | 21.1M | 411.3M | 259.9M | 161.3M | 185.4M | 161.6M | |
| Inventory | 21.9M | 19.0M | 18.3M | 32.7M | 37.6M | 20.0M | |
| Other Current Assets | 17.2M | 4.1M | 3.9M | 31.3M | 28.1M | 26.7M | |
| Total Liab | 153.2M | 155.5M | 133.5M | 122.6M | 141.0M | 125.5M | |
| Total Current Assets | 554.5M | 1.1B | 1.1B | 1.2B | 1.4B | 807.2M | |
| Intangible Assets | 25.8M | 24.6M | 23.4M | 22.1M | 25.4M | 24.9M | |
| Long Term Debt | 49.5M | 56.5M | 45.9M | 45.4M | 40.8M | 38.6M | |
| Net Receivables | 18.6M | 27.8M | 38.9M | 59.3M | 68.2M | 34.8M | |
| Net Invested Capital | 674.8M | 1.3B | 1.4B | 1.4B | 1.6B | 1.2B | |
| Short Long Term Debt | 2.7M | 19.1M | 15.7M | 5.1M | 5.8M | 9.9M | |
| Net Working Capital | 483.1M | 1.1B | 1.1B | 1.1B | 1.3B | 923.1M |
Allgens Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 1.3M | 3.4M | 1.9M | 3.1M | 3.6M | 3.8M | |
| Total Revenue | 183.8M | 236.1M | 245.3M | 226.5M | 260.4M | 200.4M | |
| Gross Profit | 154.0M | 201.5M | 204.5M | 187.2M | 215.3M | 167.0M | |
| Operating Income | 102.2M | 134.9M | 96.3M | 32.9M | 37.8M | 35.9M | |
| Ebit | 74.4M | 102.2M | 134.9M | 96.3M | 110.8M | 87.1M | |
| Research Development | 16.0M | 33.2M | 57.5M | 45.5M | 52.3M | 32.2M | |
| Ebitda | 73.7M | 111.9M | 135.8M | 106.8M | 122.8M | 92.8M | |
| Cost Of Revenue | 29.8M | 34.6M | 40.8M | 39.2M | 45.1M | 33.4M | |
| Income Before Tax | 102.1M | 132.0M | 96.2M | 49.1M | 56.5M | 81.0M | |
| Net Income | 88.9M | 120.8M | 95.2M | 54.2M | 62.4M | 76.0M | |
| Income Tax Expense | 10.4M | 15.0M | 14.0M | 4.5M | 5.2M | 10.0M | |
| Tax Provision | 15.0M | 14.0M | 4.5M | (3.9M) | (3.5M) | (3.3M) | |
| Net Interest Income | (1.2M) | 834.6K | 3.7M | 116.8K | 134.3K | 127.6K | |
| Interest Income | 127.5K | 4.3M | 5.6M | 3.3M | 3.8M | 3.0M | |
| Minority Interest | 1.8M | 2.7M | 3.5M | 1.3M | 1.1M | 2.1M |
Allgens Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Allgens Medical Tech. It measures of how well Allgens is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Allgens Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Allgens had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Allgens Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (14.6M) | 1.8M | 710.7K | (12.7M) | (11.4M) | (10.9M) | |
| Change In Cash | (54.3M) | 390.5M | (151.4M) | (98.6M) | (88.8M) | (84.3M) | |
| Free Cash Flow | 28.5M | 68.5M | 56.6M | 29.8M | 34.2M | 27.9M | |
| Change In Working Capital | (11.8M) | 6.9M | (2.5M) | (10.6M) | (9.6M) | (9.1M) | |
| Begin Period Cash Flow | 75.1M | 20.8M | 411.3M | 259.9M | 298.9M | 313.8M | |
| Other Cashflows From Financing Activities | 119.2M | 8.2M | 526.0M | (7.1M) | (8.1M) | (7.7M) | |
| Depreciation | 10.9M | 13.2M | 18.0M | 18.0M | 20.7M | 12.7M | |
| Other Non Cash Items | (1.3M) | (8.3M) | (5.2M) | 8.0M | 9.2M | 9.7M | |
| Dividends Paid | 1.4M | 1.2M | 40.1M | 17.1M | 19.6M | 11.3M | |
| Capital Expenditures | 56.4M | 61.2M | 45.4M | 21.9M | 19.7M | 18.7M | |
| Total Cash From Operating Activities | 84.9M | 129.8M | 102.1M | 51.7M | 59.4M | 89.5M | |
| Net Income | 87.1M | 118.1M | 91.7M | 54.2M | 62.4M | 73.3M | |
| Total Cash From Financing Activities | 107.2M | 4.2M | 490.2M | (55.8M) | (50.2M) | (47.7M) | |
| End Period Cash Flow | 20.8M | 411.3M | 259.9M | 161.3M | 185.4M | 161.4M | |
| Investments | (143.3M) | (229.5M) | (197.4M) | (118.1M) | (135.8M) | (142.6M) |
Allgens Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Allgens Medical's current stock value. Our valuation model uses many indicators to compare Allgens Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Allgens Medical competition to find correlations between indicators driving Allgens Medical's intrinsic value. More Info.Allgens Medical Technology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Allgens Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Allgens Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Allgens Medical Tech Systematic Risk
Allgens Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Allgens Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Allgens Medical Tech correlated with the market. If Beta is less than 0 Allgens Medical generally moves in the opposite direction as compared to the market. If Allgens Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Allgens Medical Tech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Allgens Medical is generally in the same direction as the market. If Beta > 1 Allgens Medical moves generally in the same direction as, but more than the movement of the benchmark.
Allgens Medical Technology Total Assets Over Time
Allgens Medical Thematic Clasifications
Allgens Medical Technology is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Allgens Medical February 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Allgens Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Allgens Medical Technology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Allgens Medical Technology based on widely used predictive technical indicators. In general, we focus on analyzing Allgens Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Allgens Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 13.03 | |||
| Value At Risk | (4.43) | |||
| Potential Upside | 3.46 |
Complementary Tools for Allgens Stock analysis
When running Allgens Medical's price analysis, check to measure Allgens Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allgens Medical is operating at the current time. Most of Allgens Medical's value examination focuses on studying past and present price action to predict the probability of Allgens Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allgens Medical's price. Additionally, you may evaluate how the addition of Allgens Medical to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |